List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?format=api&page=2
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 767,
    "next": "http://api.gregory-ms.com/trials/?format=api&page=3",
    "previous": "http://api.gregory-ms.com/trials/?format=api",
    "results": [
        {
            "trial_id": 427945,
            "title": "The Effect of Motor Imagery on Balance in Persons With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Falls;   Motor Imagery;   Multiple Sclerosis;   Balance;   Fatigue<br /><b>Intervention</b>:    Other: Motor Imagery as compared to physical practice for balance tasks<br /><b>Sponsor</b>:    Dominican University of New York<br /><b>Not yet recruiting</b>",
            "published_date": "2022-11-14T12:00:00Z",
            "discovery_date": "2022-11-14T13:29:35.166945Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05615207?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 427943,
            "title": "Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Erectile Dysfunction Due to Diseases Classified Elsewhere;   Multiple Sclerosis, Relapsing-Remitting<br /><b>Interventions</b>:    Device: bio-electromagnetic energy regulation therapy (BEMER) machine model type: B.BOX CLASSIC, model NO: 420100, 12-15 Volt, (BEMER Int.AG, Liechtenstein product).;   Device: placebo BEMER<br /><b>Sponsor</b>:    Imam Abdulrahman Bin Faisal University<br /><b>Not yet recruiting</b>",
            "published_date": "2022-11-14T12:00:00Z",
            "discovery_date": "2022-11-14T13:29:35.160973Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05615454?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 426577,
            "title": "Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Other: Clinical assessment;   Other: Classical cognitive evaluation of several domains:;   Other: Ecological evaluation;   Behavioral: Patent reported outcomes (PRO's);   Other: Telerehabilitation : active procedure;   Other: Telerehabilitation : comparator procedure<br /><b>Sponsors</b>:    University Hospital, Bordeaux;   Celgene<br /><b>Not yet recruiting</b>",
            "published_date": "2022-11-09T12:00:00Z",
            "discovery_date": "2022-11-09T13:22:21.097464Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05611047?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 426374,
            "title": "A Non-interventional Study Evaluating Kesimpta® (Ofatumumab) Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies [KAIROS]",
            "summary": null,
            "published_date": null,
            "discovery_date": "2022-11-09T00:15:47.456296Z",
            "link": "https://www.novartis.com//clinicaltrials/study/nct05566756",
            "source": "Novartis",
            "relevant": null
        },
        {
            "trial_id": 423964,
            "title": "Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve",
            "summary": "<b>Conditions</b>:    Demyelinating Diseases;   Multiple Sclerosis;   Neuromyelitis Optica Spectrum Disorder Attack;   Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease;   Optic Neuritis<br /><b>Intervention</b>:    Other: non-interventional study<br /><b>Sponsor</b>:    Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul<br /><b>Recruiting</b>",
            "published_date": "2022-11-04T12:00:00Z",
            "discovery_date": "2022-11-04T13:00:15.542187Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05605951?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 423961,
            "title": "A Post-Authorization, Long-term Study of Ozanimod Real-world Safety",
            "summary": "<b>Condition</b>:    Multiple Sclerosis, Relapsing-Remitting<br /><b>Intervention</b>:    <br /><b>Sponsor</b>:    Bristol-Myers Squibb<br /><b>Active, not recruiting</b>",
            "published_date": "2022-11-04T12:00:00Z",
            "discovery_date": "2022-11-04T13:00:15.536060Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05605782?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 423441,
            "title": "Lesion Load and Location in Relation to Cognition, Fatigue and Physical Disability in RRMS",
            "summary": "<b>Condition</b>:    Relapsing Remitting Multiple Sclerosis<br /><b>Interventions</b>:    Diagnostic Test: VolBrain, a fully automated platform to generate the volumetric data (lesion count, volume and location as well as different atrophy measures);   Other: Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)<br /><b>Sponsor</b>:    Assiut University<br /><b>Completed</b>",
            "published_date": "2022-11-03T12:00:00Z",
            "discovery_date": "2022-11-03T13:00:16.745266Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05604092?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 422154,
            "title": "Multiple Sclerosis and Menopause: the effect of hormone replacement therapy on clinical picture and immunology of multiple sclerosis",
            "summary": "<p>EudraCT Number: 2014-005129-10<br />Sponsor Protocol Number: Elovaara09112014<br />Sponsor Name: Irina Elovaara<br />Start Date: 2015-01-27<br />Medical condition: Multiple sclerosis<br />Disease: <br />Version: 17.1<br />SOC Term: 100000004852<br />Classification Code: 10064137<br />Term: Progression of multiple sclerosis<br />Level: LLT<br />Version: 17.1<br />SOC Term: 100000004852<br />Classification Code: 10070425<br />Term: Multiple sclerosis exacerbation<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-005129-10/FI\">FI</a> (Completed)</p>",
            "published_date": null,
            "discovery_date": "2022-11-01T06:30:17.217248Z",
            "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number%3A2014-005129-10",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 418050,
            "title": "Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Spasticity, Muscle;   Pain<br /><b>Intervention</b>:    Device: FlowOx 2.0<br /><b>Sponsor</b>:    Otivio AS<br /><b>Enrolling by invitation</b>",
            "published_date": "2022-10-28T12:00:00Z",
            "discovery_date": "2022-10-28T12:45:13.649755Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05598736?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": null,
            "relevant": null
        },
        {
            "trial_id": 416680,
            "title": "A 12-month, Prospective, Multi-center Post-authorization Commitment (PAC) Study Monitoring Safety in Adult Patients With Relapsing-remitting Multiple Sclerosis Newly Initiated on Gilenya (Fingolimod) in Taiwan (SPRING)",
            "summary": null,
            "published_date": null,
            "discovery_date": "2022-10-27T13:47:00.076321Z",
            "link": "https://www.novartis.com//clinicaltrials/study/nct04480853",
            "source": "Novartis",
            "relevant": null
        }
    ]
}